Statement from the consensus conference on anti-D prophylaxis. 7 and 8 April 1997. The Royal College of Physicians of Edinburgh. The Royal College of Obstetricians and Gynaecologists, UK.
D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D001787:Blood Group Incompatibility / Q000517:prevention & control; D003362:Cost-Benefit Analysis; D004899:Erythroblastosis, Fetal / Q000188:drug therapy* / Q000517:prevention & control; D005260:Female; D005331:Fetomaternal Transfusion / Q000150:complications / Q000188:drug therapy; D006801:Humans; D007114:Immunization / Q000592:standards; D007231:Infant, Newborn; D011247:Pregnancy; D012204:Rh-Hr Blood-Group System / Q000276:immunology; D018029:Rho(D) Immune Globulin / Q000627:therapeutic use*; D013921:Thrombocytopenia / Q000628:therapy
D000911:Antibodies, Monoclonal; D012204:Rh-Hr Blood-Group System; D018029:Rho(D) Immune Globulin